Order results by:
| Issue | Title | |
| Vol 17, No 4 (2024) | Regional aspects of availability of expectorants and antitussive drugs | Abstract similar documents |
| V. М. Timiryanova, А. V. Samorodov, Z. А. Valiullina, V. B. Prudnikov, D. Kh. Krasnoselskaya | ||
| "... differentiation in the availability of individual drugs and their price levels, which determines the variability ..." | ||
| Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
| D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
| "... of palliative care. Materials and methods. The price, affordability and physical availability ..." | ||
| Vol 17, No 1 (2024) | Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov | ||
| "... in the Russian Federation. Objective: to assess drug prices, affordability, and availability for COPD patients ..." | ||
| Vol 9, No 2 (2016) | MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE | Abstract similar documents |
| S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya | ||
| "... The use of narcotic drugs in healthcare system nowadays is characterized by lawful aspects ..." | ||
| Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract similar documents |
| V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
| "... the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian ..." | ||
| Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
| F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
| "... trends in the general picture of drug prices and consumption. In the present study, we analyze ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract similar documents |
| D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
| "... of oral vinorelbine was carried out taking into consideration the change in the price of the drug ..." | ||
| Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| "... normative legal acts (NLA) in the sphere of price formation on pharmaceutical drugs in the EAEC. The study ..." | ||
| Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| "... Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs ..." | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract similar documents |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| "... of the reviewed countries have policies controlling prices for generic drugs and employ the internal reference ..." | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract similar documents |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| "... of the reviewed countries have policies controlling prices for generic drugs and employ the internal reference ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... retail prices, inclusive of value-added tax. In case of availability of biosimilars/generics ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... study goal is to prepare a road map for development of price regulation system and system of drug ..." | ||
| Vol 12, No 3 (2019) | Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics | Abstract PDF (Eng) similar documents |
| S. V. Ponomarenko | ||
| "... The aim of the review was to analyze the availability of insulin therapy and the ways to improve ..." | ||
| Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract similar documents |
| V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
| "... for pharmacotherapeutic groups), and there are problems with the availability of veterinary drugs. The analysis ..." | ||
| Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
| E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
| "... The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
| A. V. Rudakova, I. Z. Gaydukova | ||
| "... to the registered maximum retail prices, inclusive of value-added tax. In case of availability of biosimilars ..." | ||
| Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
| V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
| "... Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs ..." | ||
| Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
| M. B. Kubaeva, Y. Sh. Guchshina | ||
| "... of anti-HIV drugs. Material and methods. The study was based on the documented medical histories of HIV ..." | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| "... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..." | ||
| Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| "... drugs, the level of price reduction as a result of trading, the amount and volume of purchases ..." | ||
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract similar documents |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| "... data VEC to 127 regions of Russia formulated price categories of drugs and the analysis of available ..." | ||
| Vol 10, No 2 (2017) | THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS | Abstract similar documents |
| V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko | ||
| "... as a major criterion in negotiations on medicine prices. The existing tools for assessing the therapeutic ..." | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... of orphan drugs and to carry out state regulation of prices, to ensure increase of regional funding ..." | ||
| Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov | ||
| "... . The costs in model are calculated on the basis of registered prices on drugs from the List of vital ..." | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| "... of drugs for the treatment of rare (orphan) diseases. Material and methods. Analysis of pharmaceutical ..." | ||
| Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract similar documents |
| A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
| "... and marketing methods, including normalization of drug costs to weighted average prices (rub/mg), ABC analysis ..." | ||
| Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
| "... Background. The introduction of innovative drugs has significantly increased the treatment ..." | ||
| Vol 17, No 1 (2024) | Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... + carboplatin” drug combination compared to “pembrolizumab + pemetrexed + carboplatin” combination in adult ..." | ||
| Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
| "... research with the requirements applicable in the Russian Federation (RF) when including drugs ..." | ||
| Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
| I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
| "... in 23 constituent entities of the Russian Federation (RF), as well as to analyze the availability ..." | ||
| Vol 13, No 4 (2020) | Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia | Abstract similar documents |
| V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura | ||
| "... The study aimed to perform a pharmacoeconomic analysis of antimicrobial drugs (AMDs) prescribed ..." | ||
| Vol 17, No 1 (2024) | STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| "... -environmental factors influencing medical and drug care for patients with chronic myeloid leukemia (CML ..." | ||
| Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
| "... period, the weighted average price (WAP) per 1 package of a drug for DM treatment increased from 472 ..." | ||
| Vol 16, No 2 (2023) | Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice | Abstract similar documents |
| M. S. Soboleva | ||
| "... , availability of a separate service area and other indicators. As criteria for the process information component ..." | ||
| Vol 17, No 3 (2024) | Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation | Abstract similar documents |
| V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov | ||
| "... centralization on the weighted average price (WAP) per 1 unit of measurement (UM) of a drug, the procurement ..." | ||
| Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
| "... a special narcotic drug prescription may increase the availability of pain relief for cancer patients ..." | ||
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract similar documents |
| V. V. Omelyanovskiy | ||
| "... the analysis of foreign pricing and drug supply public funding systems (or a so-called drug ..." | ||
| Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
| O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
| "... than other drugs because of its high efficacy in the hospital settings and its low price. We found ..." | ||
| Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
| E. A. Pyadushkina | ||
| "... to be included in the VED, for now the drug has no quoted price. Therefore, we used the price suggested ..." | ||
| Vol 10, No 2 (2017) | COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD | Abstract similar documents |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov | ||
| "... regimens were calculated from the registered data on the maximum selling prices of VED drugs or from ..." | ||
| Vol 11, No 4 (2018) | Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer | Abstract similar documents |
| N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov | ||
| "... direct medical costs (price of the drugs) of using enzalutamide or abiraterone for treatment ..." | ||
| Vol 5, No 2 (2012) | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES | Abstract similar documents |
| R. I. Yagudina, I. V. Sorokovikov | ||
| Vol 14, No 1 (2021) | Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District | Abstract similar documents |
| M. S. Soboleva, E. E. Loskutova | ||
| "... -group analysis of retail of antihypertensive drugs for 2019 in drugstores of the Khabarovsk Region ..." | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| "... to December 2015. The data of state statistical supervision, registered limit transfer drug prices from ..." | ||
| Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
| "... The recently introduced novel drug combinations for the treatment of COPD are based on long-acting ..." | ||
| Vol 10, No 2 (2017) | PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY | Abstract similar documents |
| A. V. Rudakova, S. A. Protsenko, I. A. Koroleva | ||
| "... on pricing entered with no discounts for a period of 1-5 years. The costs of the immunotherapeutic drugs were ..." | ||
| Vol 17, No 3 (2024) | Experience of using Beers criteria in clinical practice (according to Russian literature) | Abstract similar documents |
| M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev | ||
| "... departments – 90.4%, and in outpatient treatment settings – 28%. Non-steroidal anti-inflammatory drugs ..." | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... and the availability of effective medical care. The current approach of access to cancer medicines limits ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
| A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
| "... years. The calculation was based on the registered prices and VAT. If there was an original drug ..." | ||
| 1 - 50 of 273 Items | 1 2 3 4 5 6 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
